Research Articles
Propranolol Disposition in the Rat: Variation in Hepatic Extraction with Unbound Drug Fraction

https://doi.org/10.1002/jps.2600810314Get rights and content

Abstract

The plasma protein binding of propranolol has been described as nonrestrictive for its hepatic extraction to explain the observation that propranolol is efficiently removed by the liver, in spite of extensive protein binding. The present study was designed to examine the relationship between propranolol protein binding, metabolism by isolated hepatocytes, and extraction by the isolated perfused rat liver. In isolated hepatocytes, the intrinsic clearance of free drug increased three-to fourfold as albumin and α1-acid glycoprotein (AAG) concentrations increased, suggesting that albumin and AAG facilitate the elimination of propranolol by hepatocytes. In the isolated perfused liver, propranolol extraction was almost complete (E = 0.996) in the absence of albumin and AAG. With 40 g/L of albumin and 2 g/L of AAG in the perfusate, the free fraction of propranolol decreased to 0.031, but extraction remained high (E = 0.960). With 40 g/L of albumin and 10 g/L of AAG in the perfusate, the free fraction further decreased to 0.014 and extraction dropped sharply (E = 0.820). The observed relationship between propranolol extraction and the free fraction of propranolol was in good agreement with that predicted using estimates of intrinsic clearance measured in isolated hepatocytes suspensions. These data indicate that propranolol extraction is sensitive to changes in binding at very low free fraction values and suggest a facilitation of propranolol clearance by albumin and AAG.

References (0)

Cited by (16)

  • Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data

    2018, European Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Blanchard et al. (2004) observed that unbound in vitro intrinsic clearance (corrected by the in vitro unbound fraction) of mibefradil, midazolam, and RO-X can be significantly different in the presence and absence of serum in hepatocyte studies. Furthermore, Gariépy et al. (1992) demonstrated that the apparent intrinsic clearances at low (fu, pf≤0.034) and high (fu, pf=0.978) unbound fractions are significantly different in an IPRL study of propranolol. Øie and Fiori (Oie and Fiori, 1985) showed that the unbound clearance of two low hepatic clearance drugs, prazosin and antipyrine, can be altered in the presence of albumin and/or AAG in IPRL studies.

  • In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods

    2012, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    The central issue is whether the traditional assumption for drug access to the hepatocytes holds true for IVIVE. This assumption is that equilibrium between the free and protein-bound drug is instantaneous, such that the metabolism process is driven by a constant supply of unbound drug concentration in plasma.1–9 The equilibrium model generally refers to a well-stirred or parallel tube.

  • Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition

    2002, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    It is essential to scale CLint determined in vitro to the in vivo situation. The scaling of CLint in vitro was presented as follows step-by-step: (i) providing the literature data on CLint for the disappearance clearance of each drug in fresh suspensions of rat hepatocytes (μL/min/106 cells; Table 2,12,22 (ii) scaling these in vitro data on CLint with a traditional scaling factor (109 × 106 cells/g liver)23 to estimate CLint in L/min under in vivo conditions, and (iii) calculating Eh in vivo [= CLint / (CLint + Qh)] used in the mass balance differential equation of liver. In calculating Eh, the required values of Qh and liver weight were set equal to 0.0145 L/min and 9.15 g, respectively (Table 1).

View all citing articles on Scopus
View full text